Pharmaceutical Investing Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes
Pharmaceutical Investing Alder BioPharmaceuticals, Inc. Announces Offering of $200 Million of Convertible Senior Notes Due 2025
Quidel Receives FDA Clearance for Solana(R) Molecular Assay for the Detection of Herpes Simplex Virus 1+2 and Varicella Zoster Virus
Stellarex™ ILLUMENATE Pivotal Results Are Top-tier in the Most Complex Patient Group Studied in DCB IDE Trials
Cloud Investing AMD Announces Public Offerings of $600 Million of Common Stock and $450 Million of Convertible Senior Notes
Brunswick Exploration Drills 36 Meters at 1.51% and Continues to Extend the Mineralized Footprint of Mirage
